Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer

Endocrine therapies targeting oestrogen signalling have significantly improved breast cancer management. However, their efficacy is limited by intrinsic and acquired resistance to treatment, which remains a major challenge for oestrogen receptor α (ERα)-positive tumours. Though many studies using in...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Poulard, Coralie, Jacquemetton, Julien, Trédan, Olivier, Cohen, Pascale A., Vendrell, Julie, Ghayad, Sandra E., Treilleux, Isabelle, Marangoni, Elisabetta, Le Romancer, Muriel
Aineistotyyppi: Online Artikkeli Teksti
Kieli:English
Julkaistu: MDPI 2019
Aiheet:
Article
Linkit:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600329/
https://www.ncbi.nlm.nih.gov/pubmed/31195751
http://dx.doi.org/10.3390/ijms20112773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600329/
https://www.ncbi.nlm.nih.gov/pubmed/31195751
http://dx.doi.org/10.3390/ijms20112773

Samankaltaisia teoksia